Timing of Erythropoiesis-Stimulating Agent Initiation and Adverse Outcomes in Nondialysis CKD: a Propensity-Matched Observational Study

Background and objectives: The severity of anemia at which to initiate erythropoiesis-stimulating agent (ESA) treatment in nondialysis chronic kidney disease (CKD) patients is unclear. Risk of mortality, hospitalizations, and blood transfusion were compared among nondialysis CKD patients with “early...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Seliger, Stephen, Fox, Kathleen M., Gandra, Shravanthi R., Bradbury, Brian, Hsu, Van Doren, Walker, Loreen, Chiou, Chiun-Fang, Fink, Jeffrey C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Nephrology 2010
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2863974/
https://ncbi.nlm.nih.gov/pubmed/20299377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07171009
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller